Risk factors for the development of Clostridium difficile-associated colitis after colorectal cancer surgery

Journal of the Korean Society of Coloproctology

Volumn 26, Issue 5, 2010, Pages 329-333

  Yeom, Chang Ho ^a   Cho, Min Mi ^a   Baek, Seong Kyu ^a   Bae, Ok Suk ^a  

^a Dongsan Medical Center   (South Korea)

Author keywords

Clostridium difficile; Colitis; Colorectal cancer

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CANCER SURGERY; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLORECTAL CANCER; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; STENT; STOMA; TREATMENT DURATION;

EID: 78649874576     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2010.26.5.329     Document Type: Article

References (28)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
2. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38:350-4.
3. Triadafilopoulos G, Hallstone AE. Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 1991;101:685-91.
4. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002;162:2177-84.
5. Kent KC, Rubin MS, Wroblewski L, Hanff PA, Silen W. The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg 1998;227:296-301.
6. Groner JI, Edmiston CE Jr, Krepel CJ, Telford GL, Condon RE. The efficacy of oral antimicrobials in reducing aerobic and anaerobic colonic mucosal flora. Arch Surg 1989;124:281-4.
7. Clarke JS, Condon RE, Bartlett JG, Gorbach SL, Nichols RL, Ochi S. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 1977;186:251-9.
8. Lindsey JT, Smith JW, McClugage SG Jr, Nichols RL. Effects of commonly used bowel preparations on the large bowel mucosal-associated and luminal microflora in the rat model. Dis Colon Rectum 1990;33:554-60.
9. Zmora O, Pikarsky AJ, Wexner SD. Bowel preparation for colorectal surgery. Dis Colon Rectum 2001;44:1537-49.
10. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283-90.
11. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
12. Freeman HJ. Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol 2008;14:2794-6.
13. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 2004;47:1620-6.
14. Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery 2008;143:623-9.
15. Surawicz CM, McFarland LV. Pseudomembranous colitis: causes and cures. Digestion 1999;60:91-100.
16. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006;166:2518-24.
17. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273-80.
18. Lau WY, Chu KW, Poon GP, Ho KK. Prophylactic antibiotics in elective colorectal surgery. Br J Surg 1988;75:782-5.
19. Wren SM, Ahmed N, Jamal A, Safadi BY. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg 2005;140:752-6. (Pubitemid 41175699)
20. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
21. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-15.
22. Starr JM, Martin H, McCoubrey J, Gibson G, Poxton IR. Risk factors for Clostridium difficile colonisation and toxin production. Age Ageing 2003;32:657-60.
23. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial- associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46 Suppl 1:S19-31.
24. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 2007;45:1141-51.
25. Metzger R, Swenson BR, Bonatti H, Hedrick TL, Hranjec T, Popovsky KA, et al. Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann Surg 2010;251:722-7.
26. Park BS, Kim JH, Seo HI, Kim HS, Kim DH, Cho HJ, et al. Pseudomembranous Colitis after gastrointestinal operation. J Korean Surg Soc 2009;77:106-12.
27. Keighley MR, Burdon DW, Alexander-Williams J, Shinagawa N, Arabi Y, Thompson H, et al. Diarrhoea and pseudomembranous colitis after gastrointestinal operations: a prospective study. Lancet 1978;2:1165-7.
28. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:739-50.